1,496
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice

, , , , , , , , , , & show all
Pages 1-22 | Received 02 Aug 2017, Accepted 12 Nov 2017, Published online: 10 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Fan Gao, Pei Liu, Yaqian Huo, Lianlian Bian, Xing Wu, Mingchen Liu, Qian Wang, Qian He, Fangyu Dong, Zejun Wang, Zhongping Xie, Zhongyang Zhang, Meirong Gu, Yingzhi Xu, Yajing Li, Rui Zhu, Tong Cheng, Tao Wang, Qunying Mao & Zhenglun Liang. (2024) A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines. Emerging Microbes & Infections 13:1.
Read now
Qian Zhou, Yaqian Cui, Chenxiao Wang, Hanwen Wu, Haifeng Xiong, Kezong Qi & Hongmei Liu. (2024) Characterization of natural co-infection with goose astrovirus genotypes I and II in gout affected goslings. Avian Pathology 53:2, pages 146-153.
Read now
Siddharth C Umarje & Sanjiban K Banerjee. (2023) Non-traditional approaches for control of antibiotic resistance. Expert Opinion on Biological Therapy 23:11, pages 1113-1135.
Read now
Qingdong Luan, Yijun Han, Yanbo Yin & Jianlin Wang. (2022) Genetic diversity and pathogenicity of novel chicken astrovirus in China. Avian Pathology 51:5, pages 488-498.
Read now

Articles from other publishers (19)

Kota Senpuku, Chikako Kataoka-Nakamura, Yuta Kunishima, Toshiro Hirai & Yasuo Yoshioka. (2024) An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice. Vaccine 42:9, pages 2463-2474.
Crossref
Cassandra S. Grizer, Kevin Messacar & Joseph J. Mattapallil. (2024) Enterovirus-D68 – a reemerging non-polio enterovirus that causes severe respiratory and neurological disease in children. Frontiers in Virology 4.
Crossref
Wenlong Dai, Xue Li, Zeyu Liu & Chao Zhang. (2023) Identification of four neutralizing antigenic sites on the enterovirus D68 capsid. Journal of Virology 97:12.
Crossref
Xin Liu, Hanyu Zhu, Mei Wang, Ning Zhang, Jing Wang, Wenbian Tan, Guochuan Wu, Pei Yu, Hongbo Liu & Qiliang Liu. (2023) An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice. Virus Research 337, pages 199235.
Crossref
Peter W. Krug, Lingshu Wang, Wei ShiWing-Pui Kong, Daniel L. Moss, Eun Sung Yang, Brian E. FisherKaitlyn M. Morabito, John R. MascolaMasaru Kanekiyo, Barney S. Graham & Tracy J. Ruckwardt. (2023) EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination. Science Advances 9:20.
Crossref
Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad & Ravinder Kumar. (2023) Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery. Vaccines 11:2, pages 479.
Crossref
Dmitri V. Novikov & Dmitry A. Melentev. (2022) Enteroviral (<i>Picornaviridae: Enterovirus</i>) (nonpolio) vaccines. Problems of Virology 67:3, pages 185-192.
Crossref
Meghan S. Vermillion, Justin Dearing, Yun Zhang, Danielle R. Adney, Richard H. Scheuermann, Andrew Pekosz & E. Bart Tarbet. (2022) Animal Models of Enterovirus D68 Infection and Disease. Journal of Virology 96:15.
Crossref
Kaiwen Meng, Lijie Zhang, Xiaoyin Xue, Qinghong Xue, Miao Sun & Geng Meng. (2022) Structure of Senecavirus A 3C Protease Revealed the Cleavage Pattern of 3C Protease in Picornaviruses. Journal of Virology 96:13.
Crossref
Annamalai RamaAnuja PaiDivya Rosa BarretoSiva Kumar KannanAnup Naha. (2022) Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications. Research Journal of Pharmacy and Technology, pages 2801-2808.
Crossref
D. V. Novikov, D. A. Melentev, V. V. Mokhonov, A. Yu. Kashnikov, N. A. Novikova, V. A. Lapin, E. V. Mokhonova & V. V. Novikov. (2021) Construction of norovirus (Caliciviridae: Norovirus) virus-like particles containing VP1 of the Echovirus 30 (Picornaviridae: Enterovirus: Enterovirus B). Problems of Virology 66:5, pages 383-389.
Crossref
Chao Zhang, Cong Xu, Wenlong Dai, Yifan Wang, Zhi Liu, Xueyang Zhang, Xuesong Wang, Haikun Wang, Sitang Gong, Yao Cong & Zhong Huang. (2021) Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Nature Communications 12:1.
Crossref
Matthew J. Elrick, Andrew Pekosz & Priya Duggal. (2021) Enterovirus D68 molecular and cellular biology and pathogenesis. Journal of Biological Chemistry 296, pages 100317.
Crossref
Minna M. Hankaniemi, Mo A. Baikoghli, Virginia M. Stone, Li Xing, Outi Väätäinen, Saana Soppela, Amirbabak Sioofy-Khojine, Niila V. V. Saarinen, Tingwei Ou, Brandon Anson, Heikki Hyöty, Varpu Marjomäki, Malin Flodström-Tullberg, R. Holland Cheng, Vesa P. Hytönen & Olli H. Laitinen. (2020) Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine. Microorganisms 8:9, pages 1287.
Crossref
Matthew R. Vogt, Jianing Fu, Nurgun KoseLauren E. Williamson, Robin Bombardi, Ian SetliffIvelin S. GeorgievThomas Klose, Michael G. RossmannBrett L. Hurst, E. Bart Tarbet, Yury A. Bochkov, James E. GernRichard J. Kuhn & James E. CroweJr.Jr.. (2020) Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease. Science Immunology 5:49.
Crossref
Ravinder Kumar & Piyush Kumar. (2019) Yeast-based vaccines: New perspective in vaccine development and application. FEMS Yeast Research 19:2.
Crossref
Matthew R Vogt & James E CroweJrJr. (2018) Current Understanding of Humoral Immunity to Enterovirus D68. Journal of the Pediatric Infectious Diseases Society 7:suppl_2, pages S49-S53.
Crossref
Ari Bitnun & E. Ann Yeh. (2018) Acute Flaccid Paralysis and Enteroviral Infections. Current Infectious Disease Reports 20:9.
Crossref
Chao Zhang, Xueyang Zhang, Wenlong Dai, Qingwei Liu, Pei Xiong, Shuxia Wang, Lanlan Geng, Sitang Gong & Zhong Huang. (2018) A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine. Viruses 10:2, pages 58.
Crossref